University of Hawaiʻi Cancer Center Won $3 Million Grant
Researchers will study why early-stage breast cancer progresses to invasive disease in some patients.
Updated on Oct. 6, 2026 in Cancer
Live Poll
Should medical research prioritize closing health outcome gaps for underrepresented ethnic populations?
The National Cancer Institute awarded a $3 million grant to the University of Hawaiʻi Cancer Center to study ductal carcinoma in situ. The project seeks to understand why early-stage breast cancer becomes invasive, a critical concern for women in Hawaiʻi where breast cancer is the most diagnosed form of the disease.
Why it matters
Identifying why progression occurs could enable more tailored treatment plans for patients, moving away from a one-size-fits-all approach. This is particularly vital for Native Hawaiian, Filipino, and Japanese patients who face higher risks of invasive progression than White patients.
Researchers at the University of Hawaiʻi Cancer Center will conduct a five-year study comparing ductal carcinoma in situ with invasive tumors from the same patients. The research aims to define the biological and environmental factors driving disease progression.
The players
University of Hawaiʻi Cancer Center
An academic research facility focused on advancing cancer treatments and studying the unique health outcomes of the local population.
National Cancer Institute
A federal agency that serves as the primary engine for cancer research and grant funding in the United States.
The details
The research team will analyze how lifestyle, health, and social factors interact with tumor biology to drive cancer progression. By comparing non-invasive ductal carcinoma in situ to invasive tumors taken from the same patients, scientists hope to isolate the specific markers that signal a higher risk for disease advancement.
Timeline
October 2026 marks Breast Cancer Awareness Month.
Health Landscape
This research reflects a broader shift toward precision oncology, moving beyond standard detection to understand the biology of disease progression. It aligns with the National Cancer Institute's ongoing efforts to address health disparities in oncology outcomes.
If you have received a diagnosis of ductal carcinoma in situ, it is worth discussing the latest risk assessment options with your oncologist. Ask about whether your specific genetic or lifestyle factors place you at a higher risk for progression to invasive disease.
The takeaway
Understanding why early-stage breast cancer progresses is the first step toward personalized management and prevention. Patients should track their personal and family health history to ensure they are getting the most appropriate screening and follow-up care from their physician.
Further reading
Find more updates and research on local health initiatives in our Cancer section.
Source note: This article includes information reported by Big Island Now | Big Island News and Information.
Live Poll
Should medical research prioritize closing health outcome gaps for underrepresented ethnic populations?
